It has been shown in many studies that episodic use of infliximab (and other Anti-TNF agents) increases the incidence of antibody formation towards the drug, when compared with giving the drug on a regular schedule, such as once every 8 weeks 1. Why is this? 1:Incidence and importance of antibo...